Log in to the research portal to view current pricing, stock, and bundles and order.
Specialty research peptides in this catalog
Why these compounds are grouped as specialty signaling peptides
Unlike a category organized around a single shared mechanism, this collection is unified by a higher-order theme: each member is a specialized signaling peptide that acts on a distinct endocrine, sleep, or immune-vascular system. Gonadorelin and HCG sit within the hypothalamic-pituitary-gonadal (HPG) axis but at different levels of that cascade. DSIP is investigated within neuroendocrine and sleep-architecture research. VIP is studied as a vasoactive and immunomodulatory neuropeptide. What ties them together is that all four are peptide messengers whose biology is receptor-specific and tissue-specific, making them frequent reference compounds in mechanistic studies.
Because the systems differ, researchers rarely select these peptides interchangeably. The selection logic is target-driven: a study of pulsatile gonadotropin release reaches for a different molecule than a study of delta-wave electroencephalographic patterns or vascular smooth-muscle relaxation. Grouping them as specialty research peptides reflects how laboratories actually organize work around the receptor and the downstream pathway under investigation rather than around a chemical family.
Across the published literature, these peptides recur as well-characterized probes. Their receptor pharmacology, signaling cascades, and tissue distributions have been mapped in animal models and isolated-cell systems, which is precisely why they remain useful as controlled inputs in experimental designs that need a defined, reproducible signal.
The HPG-axis pair: Gonadorelin and HCG at different levels
Gonadorelin is a synthetic form of gonadotropin-releasing hormone (GnRH), the decapeptide secreted by the hypothalamus. In animal and in-vitro research, GnRH acts at the top of the HPG axis: it binds GnRH receptors on pituitary gonadotrope cells and stimulates the synthesis and release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). A defining feature documented in the literature is that this signaling is pulsatile. Studies have shown that the frequency and amplitude of GnRH pulses shape the downstream gonadotropin profile, and that continuous, non-pulsatile exposure can produce receptor desensitization in experimental models.
HCG (Human Chorionic Gonadotropin) is positioned much lower in the same axis. Rather than acting on the pituitary, HCG functions in research models as an LH-mimetic: it binds the LH/choriogonadotropin receptor on gonadal cells, bypassing the hypothalamic and pituitary stages entirely. In published preclinical work, this receptor engagement has been used to study gonadal-cell steroidogenesis and the signaling cascades that LH normally triggers, with HCG serving as a long-acting agonist at that receptor.
The contrast is the analytically useful point. Gonadorelin is a hypothalamic-level input that drives the entire cascade through the pituitary and depends on pulsatile delivery; HCG is a gonadal-level input that acts directly on the end-organ receptor. A researcher studying the integrity of the pituitary response selects the GnRH-axis compound, while a researcher isolating gonadal receptor signaling selects the LH-mimetic. Together they let investigators interrogate the HPG axis at two separate control points.
Sleep and neuroendocrine research: DSIP
DSIP (Delta Sleep-Inducing Peptide) is a nonapeptide first isolated from cerebral venous blood in studies associated with sleep states. In the animal research literature it is named for its observed association with delta-wave (slow-wave) electroencephalographic activity. Investigations have examined how DSIP correlates with sleep architecture and how it distributes across central and peripheral tissues, positioning it as a probe in neuroendocrine and chronobiology research rather than as a compound with a single cleanly mapped receptor.
Beyond its sleep-associated naming, DSIP has been studied for a range of neuroendocrine interactions in preclinical models, including reported modulation of certain hormone-release patterns and stress-response markers. The literature treats its mechanism as incompletely resolved, which is itself a research driver: studies continue to probe whether its effects are mediated through a dedicated receptor, through interactions with other neuropeptide systems, or through broader neuromodulatory routes.
Within this category, DSIP represents the sleep and central-neuroendocrine axis, distinct from the gonadal endocrinology of the HPG pair and from the vascular-immune focus of VIP. It is referenced in research aimed at understanding slow-wave sleep regulation and the peptide signaling that accompanies different sleep stages in experimental organisms.
Vasoactive and immune research: VIP
VIP (Vasoactive Intestinal Peptide) is a 28-amino-acid neuropeptide belonging to the secretin-glucagon peptide superfamily. In research models it signals primarily through the VPAC1 and VPAC2 G-protein-coupled receptors. Activation of these receptors has been characterized in the literature as producing vasodilation through relaxation of vascular and other smooth muscle, which is the property reflected in the peptide's name.
VIP is also extensively studied as an immunomodulatory neuropeptide. Preclinical and in-vitro work has documented its influence on immune-cell signaling and inflammatory-mediator profiles, making it a reference compound in neuroimmunology. A further area of investigation is its role in circadian biology: VIP signaling within the suprachiasmatic nucleus (SCN) of the hypothalamus has been studied as a coupling factor that helps synchronize the network of neurons constituting the central circadian clock in animal models.
This breadth, vascular tone, immune modulation, and circadian coupling, makes VIP the immune-vascular and chronobiological member of the category. Its VPAC-receptor pharmacology and its SCN signaling role give researchers defined handles for studying smooth-muscle relaxation, neuroimmune crosstalk, and clock synchronization within distinct experimental systems.
How researchers select among them by target system
Selection across this category follows the target system, not a shared chemistry. For work on the upper HPG axis and pulsatile gonadotropin release, the GnRH compound Gonadorelin is the reference input, with experimental designs often built around its pulse-frequency dependence. For work isolating gonadal-receptor signaling downstream of the pituitary, the LH-mimetic HCG is selected because it engages the LH/CG receptor directly.
For sleep-architecture and central-neuroendocrine questions, DSIP is the relevant probe, chosen when the research focus is slow-wave activity and associated neuropeptide signaling. For vascular, immune, or circadian questions, VIP is selected for its VPAC-receptor and SCN-coupling biology. Because the four peptides map cleanly onto four different physiological systems, the choice is usually unambiguous once the research question and target receptor are defined.
This target-driven framing also guides experimental controls. A study using one of these peptides typically pairs it with receptor-specific antagonists or knockdown systems documented for that pathway, reinforcing that each compound is valued for the precision of its known mechanism rather than for any cross-category effect.
Reconstitution, storage, and purity considerations
Peptides in this category are generally supplied as lyophilized (freeze-dried) powder, the form in which short peptides remain most stable for storage and shipping. In published laboratory protocols, reconstitution is typically performed with bacteriostatic or sterile water to prepare a defined stock concentration for in-vitro or animal-model research, with the diluent and concentration recorded as part of the experimental method.
Storage handling follows standard peptide-research practice. Lyophilized material is commonly held frozen and protected from light and moisture, while reconstituted solutions are kept refrigerated for short-term use and aliquoted frozen to limit repeated freeze-thaw cycles that can degrade peptide integrity. These conditions are documented because peptide stability directly affects the reproducibility of experimental results.
Purity is a central variable in this work. Research-grade documentation usually reports purity by high-performance liquid chromatography (HPLC) and identity by mass spectrometry, so that investigators can attribute observed effects to the intended peptide rather than to contaminants. All handling described here pertains exclusively to laboratory research. These materials are not FDA approved and are not for human or animal consumption.
Research application areas
Choosing a compound for your research
Choose Gonadorelin when the research target is the upper HPG axis: GnRH-receptor signaling, pituitary LH and FSH release, and the effects of pulsatile versus continuous stimulation.
Choose HCG when the target is the gonadal end-organ: it acts as an LH-mimetic at the LH/CG receptor, bypassing the hypothalamic and pituitary stages to study gonadal-cell signaling directly.
Choose DSIP when the focus is slow-wave (delta) sleep, sleep architecture, or central neuroendocrine signaling in animal and in-vitro models.
Choose VIP when the research concerns vasoactive smooth-muscle relaxation, VPAC1/VPAC2-receptor pharmacology, immunomodulation, or suprachiasmatic-nucleus circadian coupling.
Match each compound to its receptor system rather than treating the category as interchangeable; the four peptides map onto four distinct physiological pathways.
Confirm research-grade purity (HPLC) and identity (mass spectrometry) documentation, and plan reconstitution and storage to preserve peptide stability across the study.
Per-compound reference data: Gonadorelin reference · DSIP reference · VIP reference · Ovagen reference · Vesugen reference.
Frequently asked questions
What links Gonadorelin, HCG, DSIP, and VIP as one category?
They are grouped as specialty signaling peptides because each acts on a distinct endocrine, sleep, or immune-vascular system rather than sharing one mechanism. Gonadorelin and HCG operate within the HPG axis at different levels, DSIP is studied in sleep and neuroendocrine research, and VIP is a vasoactive, immunomodulatory neuropeptide. The unifying theme is that all four are receptor-specific peptide messengers used as reference probes in mechanistic laboratory studies. All are for research use only.
How do Gonadorelin and HCG differ within the HPG axis?
They act at different levels of the same cascade. Gonadorelin is a GnRH form that binds pituitary GnRH receptors to drive LH and FSH release, and its signaling is pulsatile in research models. HCG sits lower in the axis as an LH-mimetic, binding the gonadal LH/CG receptor directly and bypassing the hypothalamus and pituitary. Researchers select Gonadorelin to study the upper axis and HCG to isolate gonadal-receptor signaling. Both are research-use-only compounds.
Why is DSIP named for delta sleep?
DSIP (Delta Sleep-Inducing Peptide) was isolated in studies associated with sleep states and named for its observed correlation with delta-wave, or slow-wave, electroencephalographic activity in animal research. The literature treats its precise receptor mechanism as still under investigation, so it is studied as a probe in sleep-architecture and neuroendocrine research rather than as a fully mapped single-receptor agonist. It is supplied strictly for laboratory research and is not for human or animal consumption.
What receptors does VIP act on in research models?
VIP signals mainly through the VPAC1 and VPAC2 G-protein-coupled receptors. Activation has been characterized as producing smooth-muscle relaxation and vasodilation, the basis of its vasoactive name. VIP is also studied as an immunomodulatory neuropeptide and as a circadian coupling factor in the suprachiasmatic nucleus. These distinct roles make it the immune-vascular and chronobiological member of this category in preclinical and in-vitro studies.
How are these peptides typically reconstituted and stored in research settings?
They are usually supplied as lyophilized powder. Published laboratory protocols reconstitute them with bacteriostatic or sterile water to a defined stock concentration for in-vitro or animal-model work. Lyophilized material is commonly stored frozen and protected from light and moisture, while reconstituted solutions are refrigerated for short-term use and aliquoted frozen to limit freeze-thaw degradation. These steps support reproducibility and apply only to research handling.
Are these compounds approved for human use?
No. Every compound in this category is supplied strictly for laboratory and in-vitro research use only. They are not FDA approved and are not for human or animal consumption. The scientific summaries here describe what these peptides have been observed to do in living organisms and isolated tissues within published preclinical literature, in third-person scientific terms, and are not guidance for use in people.
Create a free research account to view current pricing, real-time stock, and bundle options, then submit your order for approval.
Related: What are peptides? · Reference library · Cost & pricing · Price comparison · Research guides · Order portal